BIOFRONTERA AG NA O.N./ DE0006046113 /
| 2024-04-19 10:13:46 AM | Chg. -0.052 | Volume | Bid12:07:35 PM | Ask12:07:35 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 0.298EUR | -14.86% | 20,077 Turnover: 6,015.100 |
0.304Bid Size: 4,000 | 0.334Ask Size: 3,500 | 16.45 mill.EUR | 0.00% | 0.42 |
Assets
| 2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | .3000 | .5000 | .3000 | .4000 | .6000 | ||||||
| Intangible Assets | 3.8000 | 3.2000 | 2.6000 | 1.9000 | 1.3000 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Fixed Assets | 4.1000 | 3.7000 | 2.9000 | 2.3000 | 1.9000 | ||||||
| Inventories | .9000 | .8000 | 1.4000 | 1.5000 | 3.6000 | ||||||
| Accounts Receivable | .3000 | .6000 | .3000 | .9000 | 1.6000 | ||||||
| Cash and Cash Equivalents | 3.4000 | 2.9000 | 8.5000 | 4 | 15.1000 | ||||||
| Current Assets | 5 | 6 | 11.1000 | 7.2000 | 22 | ||||||
| Total Assets | 9 | 9.6000 | 14 | 9.5000 | 23.9000 | ||||||
Liabilities
| 2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | .7000 | .7000 | 1 | 1 | 2.1000 | ||||||
| Long-term debt | 11.2000 | 12 | 10.8000 | 11.2000 | 3.6000 | ||||||
| Liabilities to Banks | 11.6000 | 12.4000 | 12 | 12.1000 | 3.9000 | ||||||
| Provisions | .7000 | .9100 | 1 | 1 | 1.8000 | ||||||
| Liabilities | 14.2000 | 14.2000 | 14 | 14.3000 | 8 | ||||||
| Share Capital | 16.1000 | 17.8000 | 22.1970 | 25.4900 | 37.7220 | ||||||
| Total Equity | -4.1000 | -4.5000 | -.0200 | -4.8000 | 15.8000 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 9 | 9.6000 | 14 | 9.5000 | 23.9000 | ||||||
Income Statement
| 2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 3.4000 | 3.1000 | 3.1000 | 4.1000 | 6.1000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -3.6000 | -7.1000 | -9.5000 | -10.2000 | -11.8000 | ||||||
| Interest Income | - | - | -1.1000 | -1.1900 | -1.1970 | ||||||
| Income Before Taxes | -4.1000 | -8.1000 | -10.7000 | -11.2000 | -10.6000 | ||||||
| Income Taxes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -4.1000 | -8.1000 | -10.7000 | -11.2000 | -10.6000 | ||||||
Per Share
Cash Flow
| 2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -5.2000 | -7.7000 | -7.9000 | -9.7000 | -10.7000 | ||||||
| Cash Flow from Investing Activities | -.1000 | -.3000 | .0800 | .0200 | -.5000 | ||||||
| Cash Flow from Financing | 8.1000 | 7.6000 | 13.4000 | 5.2000 | 22.4000 | ||||||
| Decrease / Increase in Cash | 2.8000 | -.4000 | 5.6000 | -4.6000 | 11.2000 | ||||||
| Employees | 34 | 38 | 46 | 58 | 94 | ||||||
